(Q35613704)

9 August 2017

1 reference

title

Non-nicotinic neuropharmacological strategies for nicotine dependence: beyond bupropion (English)

1 reference

9 August 2017

0 references

1 reference

John F Cryan

1

0 references

author name string

Fabrizio Gasparini

series ordinal

2

1 reference

9 August 2017

Gino van Heeke

series ordinal

3

1 reference

9 August 2017

Athina Markou

series ordinal

4

1 reference

9 August 2017

publication date

1 November 2003

1 reference

9 August 2017

1 reference

9 August 2017

volume

8

1 reference

9 August 2017

issue

22

1 reference

9 August 2017

page(s)

1025-1034

1 reference

Treating tobacco use and dependence: an evidence-based clinical practice guideline for tobacco cessation

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902890-3

7 January 2021

The scientific case that nicotine is addictive.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902890-3

7 January 2021

Recent advances in the pharmacotherapy of smoking

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902890-3

7 January 2021

Efficacy of bupropion for smoking cessation in smokers with a former history of major depression or alcoholism

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902890-3

7 January 2021

Intervention for relapse to smoking: the Lung Health Study restart programs

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902890-3

7 January 2021

Neuroadaptations to chronic exposure to drugs of abuse: relevance to depressive symptomatology seen across psychiatric diagnostic categories

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902890-3

7 January 2021

Mediating mechanisms for the impact of bupropion in smoking cessation treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902890-3

7 January 2021

Smoking, smoking cessation, and major depression

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902890-3

7 January 2021

A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902890-3

7 January 2021

Neurobiological similarities in depression and drug dependence: a self-medication hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902890-3

7 January 2021

Effect of nonnicotine pharmacotherapy on smoking behavior

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902890-3

7 January 2021

Bupropion enhances brain reward function and reverses the affective and somatic aspects of nicotine withdrawal in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902890-3

7 January 2021

Influence of fluoxetine on the ability of bupropion to modulate extracellular dopamine and norepinephrine concentrations in three mesocorticolimbic areas of rats

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902890-3

7 January 2021

Bupropion occupancy of the dopamine transporter is low during clinical treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902890-3

7 January 2021

Modulation of nicotine self-administration in rats by combination therapy with agents blocking alpha 3 beta 4 nicotinic receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902890-3

7 January 2021

Characterization of the effects of bupropion on the reinforcing properties of nicotine and food in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902890-3

7 January 2021

Investigating the actions of bupropion on dependence-related effects of nicotine in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902890-3

7 January 2021

Effect of bupropion on nicotine self-administration in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902890-3

7 January 2021

Mecamylamine combined with nicotine skin patch facilitates smoking cessation beyond nicotine patch treatment alone

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902890-3

7 January 2021

Nicotine and bupropion share a similar discriminative stimulus effect

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902890-3

7 January 2021

Neurobiology of the nicotine withdrawal syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902890-3

7 January 2021

Roles of dopamine signaling in nicotine addiction

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902890-3

7 January 2021

The potential of dopamine agonists in drug addiction

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902890-3

7 January 2021

A review of the effects of dopaminergic agents on humans, animals, and drug-seeking behavior, and its implications for medication development. Focus on GBR 12909.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902890-3

7 January 2021

Dopamine D3 receptor agents as potential new medications for drug addiction.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902890-3

7 January 2021

Increased dopamine D3 receptor expression accompanying behavioral sensitization to nicotine in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902890-3

7 January 2021

Selective inhibition of cocaine-seeking behaviour by a partial dopamine D3 receptor agonist

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902890-3

7 January 2021

Attenuation of cue-controlled cocaine-seeking by a selective D3 dopamine receptor antagonist SB-277011-A

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902890-3

7 January 2021

Dopamine D3 receptor antagonism inhibits cocaine-seeking and cocaine-enhanced brain reward in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902890-3

7 January 2021

Disruption of nicotine conditioning by dopamine D(3) receptor ligands

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902890-3

7 January 2021

Selective antagonism at dopamine D3 receptors prevents nicotine-triggered relapse to nicotine-seeking behavior

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902890-3

7 January 2021

Regional variation in the effects of nicotine on catecholamine overflow in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902890-3

7 January 2021

Norepinephrine secretion in the hypothalamic paraventricular nucleus of rats during unlimited access to self-administered nicotine: An in vivo microdialysis study.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902890-3

7 January 2021

Effects of long-term cigarette smoking on the human locus coeruleus

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902890-3

7 January 2021

Reboxetine: attenuation of intravenous nicotine self-administration in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902890-3

7 January 2021

Stopping smoking: a prospective, randomized, double-blind study comparing nortriptyline to placebo

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902890-3

7 January 2021

The effects of nicotine on neural pathways implicated in depression: a factor in nicotine addiction?

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902890-3

7 January 2021

Nicotinic--serotonergic interactions in brain and behaviour

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902890-3

7 January 2021

Fluoxetine combined with a serotonin-1A receptor antagonist reversed reward deficits observed during nicotine and amphetamine withdrawal in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902890-3

7 January 2021

Activation of 5-HT(2C) receptors reduces the locomotor and rewarding effects of nicotine

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902890-3

7 January 2021

Glutamatergic mechanisms in addiction

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902890-3

7 January 2021

Pharmacology and functions of metabotropic glutamate receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902890-3

7 January 2021

Stimulation of the ventral subiculum of the hippocampus evokes glutamate receptor-mediated changes in dopamine efflux in the rat nucleus accumbens.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902890-3

7 January 2021

N-methyl-D-aspartate receptor antagonism in the ventral tegmental area diminishes the systemic nicotine-induced dopamine release in the nucleus accumbens

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902890-3

7 January 2021

Low doses of dizocilpine block the development and subsequent expression of locomotor sensitization to nicotine in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902890-3

7 January 2021

Group II metabotropic and alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA)/kainate glutamate receptors regulate the deficit in brain reward function associated with nicotine withdrawal in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902890-3

7 January 2021

LY354740: a metabotropic glutamate receptor agonist which ameliorates symptoms of nicotine withdrawal in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902890-3

7 January 2021

Reinforcing and locomotor stimulant effects of cocaine are absent in mGluR5 null mutant mice

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902890-3

7 January 2021

The mGluR5 antagonist MPEP decreased nicotine self-administration in rats and mice

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902890-3

7 January 2021

International Union of Pharmacology. XXXIII. Mammalian gamma-aminobutyric acid(B) receptors: structure and function

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902890-3

7 January 2021

Increased GABA neurotransmission via administration of gamma-vinyl GABA decreased nicotine self-administration in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902890-3

7 January 2021

Systemic administration of 1R,4S-4-amino-cyclopent-2-ene-carboxylic acid, a reversible inhibitor of GABA transaminase, blocks expression of conditioned place preference to cocaine and nicotine in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902890-3

7 January 2021

Vigabatrin-associated retinal cone system dysfunction: electroretinogram and ophthalmologic findings

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902890-3

7 January 2021

Baclofen antagonizes intravenous self-administration of nicotine in mice and rats

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902890-3

7 January 2021

Response of nicotine self-administration in the rat to manipulations of mu-opioid and gamma-aminobutyric acid receptors in the ventral tegmental area

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902890-3

7 January 2021

GABA mechanisms in the pedunculopontine tegmental nucleus influence particular aspects of nicotine self-administration selectively in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902890-3

7 January 2021

Baclofen antagonizes nicotine-, cocaine-, and morphine-induced dopamine release in the nucleus accumbens of rat

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902890-3

7 January 2021

A potential role for GABA(B) agonists in the treatment of psychostimulant addiction

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902890-3

7 January 2021

Baclofen efficacy in reducing alcohol craving and intake: a preliminary double-blind randomized controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902890-3

7 January 2021

N,N'-Dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine (GS39783) and structurally related compounds: novel allosteric enhancers of gamma-aminobutyric acidB receptor function.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902890-3

7 January 2021

Positive allosteric modulators for gamma-aminobutyric acid(B) receptors open new routes for the development of drugs targeting family 3 G-protein-coupled receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902890-3

7 January 2021

Behavioural and biochemical evidence for interactions between Delta 9-tetrahydrocannabinol and nicotine.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902890-3

7 January 2021

Lack of CB1 cannabinoid receptors modifies nicotine behavioural responses, but not nicotine abstinence.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902890-3

7 January 2021

Cannabinoid CB1 receptor knockout mice fail to self-administer morphine but not other drugs of abuse

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902890-3

7 January 2021

SR141716, a central cannabinoid (CB(1)) receptor antagonist, blocks the motivational and dopamine-releasing effects of nicotine in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902890-3

7 January 2021

The CB1 receptor antagonist SR141716A selectively increases monoaminergic neurotransmission in the medial prefrontal cortex: implications for therapeutic actions

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902890-3

7 January 2021

Stress-induced relapse to heroin and cocaine seeking in rats: a review

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902890-3

7 January 2021

Response of the hypothalamo-pituitary-adrenal axis to nicotine

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902890-3

7 January 2021

Stress reinstates nicotine seeking but not sucrose solution seeking in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902890-3

7 January 2021

CP-154,526, a selective, non-peptide antagonist of the corticotropin-releasing factor1 receptor attenuates stress-induced relapse to drug seeking in cocaine- and heroin-trained rats

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902890-3

7 January 2021

Active immunization against nicotine prevents reinstatement of nicotine-seeking behavior in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902890-3

7 January 2021

SSR591813, a novel selective and partial alpha4beta2 nicotinic receptor agonist with potential as an aid to smoking cessation

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902890-3

7 January 2021

Dissociating nicotine and nonnicotine components of cigarette smoking.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902890-3

7 January 2021

Elucidating the role of genetic factors in smoking behavior and nicotine dependence

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902890-3

7 January 2021

10.1016/S1359-6446(03)02890-3

Identifiers

DOI

1 reference

9 August 2017

1 reference